FIBRONOX, L.L.C.
Biotech · Private
Selective Nox4 inhibitor small molecule drug candidates for fibrotic diseases
- Grants
- $2.6M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Therapeutic targeting of Nox2 and Nox4 in Duchenne Muscular Dystrophy | $248,019 | |
| Federal grant | Department of Health and Human Services · Phase I · Repurposing of FDA-approved Nrf2 Activators as a Novel Inhaled Therapy for Pulmonary Fibrosis | $286,739 | |
| Federal grant | Department of Health and Human Services · Phase II · Advanced Pre-clinical development of Nox4 inhibitors for Pulmonary Fibrosis | $954,681 | |
| Federal grant | Department of Health and Human Services · Phase II · Advanced Pre-clinical development of Nox4 inhibitors for Pulmonary Fibrosis | $1,091,039 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2471 | BIOSTRATEGIES LC | — | — |
| 2472 | Fulgent Pharma LLC | — | $5.4M |
| 2473 | Kestrel Therapeutics Inc. | — | $21M |
| 2474 | FIBRONOX, L.L.C. | — | — |
| 2475 | Aulos Bioscience, Inc. | — | $20M |
| 2476 | Surf Bio, Inc. | — | $16M |
| 2477 | ImmunGene | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.